Phase Forward is a provider of integrated data collection and data management solutions for clinical trials and drug safety.
Business Model:
Revenue: $0
Employees: 501-1,000
Phase Forward was acquired by
Oracle.
The acquisition happend on 2010-04-20.
Details of the transaction were not public
Address:
City: Waltham
State: Massachusetts
Zip:
Country: United States
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward&s;s technology and global services are designed to enable life sciences companies to automate and integrate the management of their entire clinical development process, from study initiation and FDA submission through post-marketing studies. Until its acquisition by Oracle in April 2010, Phase Forward was a publicly held company. Its corporate headquarters were in Waltham, Massachusetts, international headquarters in Maidenhead, UK, and its regional offices in the U.S., Japan, France and Australia. Phase Forward was founded in 1997 by Paul Bleicher, M.D, Ph.D., who had experienced firsthand the complexities involved in developing and conducting paper-based trials, in particular, capturing, managing, and growing volumes of data. Dr. Bleicher&s;s vision was to develop technology that would enable organizations to make the shift from paper-based methods to Internet-enabled solutions. His pioneering efforts have contributed significantly to Phase Forward&s;s evolution from initial concept to its current industry-leading position. Spearheading the evolution of electronic data capture (EDC) with its industry-leading InForm solution, Phase Forward transformed the way clinical data are collected, analyzed and managed. With the acquisition of Lincoln Technologies&s; innovative safety management solutions, Phase Forward took steps to provide the end-to-end solutions customers need to track and monitor product efficacy and safety, while building their trials more efficiently and cost-effectively.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/15/2004
Ticker Symbol:
PFWD
IPO Price:
$7.5/share
Amount Raised:
$39M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2001 | Venture Round | 1 | - |
New Enterprise Associates New Enterprise Associates |
8/2000 | Venture Round | 9 | $25M |
Thomas Weisel Partners Sprout Group North Bridge Venture Partners &a; Growth Equity Bioventures Investors SV Health Investors HLM Venture Partners Housatonic Partners Pacific Venture Group Atlas Venture Thomas Weisel Partners Thomas Weisel Partners Sprout Group North Bridge Venture Partners &a; Growth Equity Bioventures Investors SV Health Investors HLM Venture Partners Housatonic Partners Pacific Venture Group Atlas Venture Thomas Weisel Partners |
1/2001 | Venture Round | 1 | - |
New Enterprise Associates New Enterprise Associates |
---|
Announced Date | Name | Price |
---|---|---|
7/2009 | Maaguzi | |
7/2009 | Covance - Web Response Services (IVRS/IWRS) business | |
4/2009 | Waban Software | |
8/2005 | Lincoln Technologies | |
8/2001 | Clinsoft Corporation | |
3/2001 | Provenda Biometrics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|